Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-108,061
Closed -$412K 751
2023
Q1
$412K Sell
108,061
-50,914
-32% -$267K ﹤0.01% 817
2022
Q4
$741K Buy
158,975
+16,022
+11% +$87.8K 0.01% 757
2022
Q3
$866K Buy
+142,953
New +$1.15M 0.01% 736
2020
Q2
Sell
-89,854
Closed -$1.4M 814
2020
Q1
$1.4M Buy
89,854
+81
+0.1% +$1.13K 0.02% 598
2019
Q4
$1.44M Buy
89,773
+62,329
+227% +$922K 0.02% 615
2019
Q3
$376K Hold
27,444
0.01% 705
2019
Q2
$504K Buy
+27,444
New +$529K 0.01% 729

Other funds holding CDXS

Candriam SCA's CDXS Position: Q2 2023 in Review

Candriam SCA sold out of Codexis (CDXS) in Q2 2023, closing a stake of 108,061 shares — an estimated $412K sold.

Candriam SCA first reported a position in CDXS in Q2 2019 and held it in 7 quarters. The position peaked at $1.44M in Q4 2019. 126 funds tracked by Wall St. Rank hold CDXS as of Q2 2023.

  • Candriam SCA reported no remaining Codexis position as of Q2 2023 after selling out during the quarter.
  • Candriam SCA sold 108,061 Codexis shares in Q2 2023, an estimated $412K.
  • Candriam SCA first reported a position in Codexis in Q2 2019 and held it in 7 quarters.
  • Candriam SCA's Codexis position peaked at $1.44M in Q4 2019.
  • 126 funds tracked by Wall St. Rank held Codexis as of Q2 2023.

Based on Candriam SCA's 13F filing for Q2 2023, filed 8 Aug 2023.